What is Neuron Guard?
Established in 2013, Neuron Guard is an innovative small and medium-sized enterprise (SME) dedicated to the development and manufacturing of advanced medical devices for selective and portable cerebral targeted temperature management. The company directly addresses the substantial healthcare challenge posed by Acquired Brain Injury (ABI), a condition affecting millions annually across North America and Europe and leading to considerable long-term disabilities and healthcare expenditures. Neuron Guard's flagship product, CB240_AURORA, is engineered to be a user-friendly solution, enhancing treatment efficiency and mitigating systemic complications through precise brain cooling. Their primary clientele includes healthcare providers and emergency medical services seeking effective and cost-efficient solutions for acute brain injury management.
How much funding has Neuron Guard raised?
Neuron Guard has raised a total of $717K across 1 funding round:
Unspecified
$717K
Unspecified (2015): $717K with participation from A11 Venture
Key Investors in Neuron Guard
A11 Venture
A11 Venture is an Italian capital investment company with a strategic focus on robotics, automation, and mechatronics, indicating a potential interest in the technological and engineering aspects of Neuron Guard's medical device.
What's next for Neuron Guard?
With the recent major strategic investment, Neuron Guard is poised for significant expansion and further product development. This capital infusion is expected to accelerate the company's market penetration and enhance its manufacturing capabilities for the CB240_AURORA device. The strategic nature of this financing suggests a focus on scaling operations, forging key partnerships within the healthcare sector, and potentially expanding research and development efforts to broaden their therapeutic applications. Neuron Guard's trajectory indicates a move towards solidifying its position as a leader in neuro-protection technologies.
See full Neuron Guard company page
